Question 1

How many shares of NXTC does CITADEL ADVISORS LLC own?

Accepted Answer

CITADEL ADVISORS LLC previously held 0 shares of NXTC (NextCure, Inc.) before exiting the position in 2026-Q2.

Question 2

What is CITADEL ADVISORS LLC's NXTC position worth?

Accepted Answer

CITADEL ADVISORS LLC's NXTC position was last reported at $0 in 2026-Q2 before the exit.

Question 3

Is CITADEL ADVISORS LLC buying or selling NXTC?

Accepted Answer

In 2026-Q2, CITADEL ADVISORS LLC exited their NXTC position entirely (-100.0% change in shares).

Question 4

When did CITADEL ADVISORS LLC first buy NXTC?

Accepted Answer

Based on available 13F filings, CITADEL ADVISORS LLC first reported a position in NXTC in 2024-Q3. They have held the position across 28 quarters.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q2 Latest	Exited	0	-100.0%	$0	0.0%	$1.60	0
2026-Q1	New	15,292	—	$160,872	0.0%	$12.05	34
2025-Q3	Exited	0	-100.0%	$0	0.0%	$5.79	0
2025-Q2	Decreased	58,845	-35.1%	$27,069	0.0%	$5.40	0
2025-Q1	Increased	90,643	+15.2%	$43,536	0.0%	$5.99	16
2024-Q4	Increased	78,678	+40.6%	$60,661	0.0%	$9.96	19
2024-Q3	Decreased	55,954	-80.6%	$76,657	0.0%	$16.56	0